
HHS, NIH Launch Next-Generation Universal Vaccine Platform for Pandemic-Prone Viruses
This initiative represents a decisive shift toward transparency, effectiveness, and comprehensive preparedness, funding the NIH’s in-house development of universal influenza and coronavirus vaccines, including candidates BPL-1357 and BPL-24910.